Belluscura (BELL) Competitors GBX 10.05 -0.20 (-1.95%) (As of 11/15/2024 11:38 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors BELL vs. CREO, IUG, NCYT, POLX, IHC, AVO, RUA, MHC, SUN, and DEMGShould you be buying Belluscura stock or one of its competitors? The main competitors of Belluscura include Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), MyHealthChecked (MHC), Surgical Innovations Group (SUN), and Deltex Medical Group (DEMG). These companies are all part of the "medical devices" industry. Belluscura vs. Creo Medical Group Intelligent Ultrasound Group Novacyt Polarean Imaging Inspiration Healthcare Group Advanced Oncotherapy RUA Life Sciences MyHealthChecked Surgical Innovations Group Deltex Medical Group Belluscura (LON:BELL) and Creo Medical Group (LON:CREO) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, media sentiment, community ranking, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability. Does the MarketBeat Community prefer BELL or CREO? Creo Medical Group received 106 more outperform votes than Belluscura when rated by MarketBeat users. CompanyUnderperformOutperformBelluscuraN/AN/ACreo Medical GroupOutperform Votes10667.52% Underperform Votes5132.48% Is BELL or CREO more profitable? Belluscura has a net margin of 0.00% compared to Creo Medical Group's net margin of -73.93%. Creo Medical Group's return on equity of -38.49% beat Belluscura's return on equity.Company Net Margins Return on Equity Return on Assets BelluscuraN/A -85.01% -43.53% Creo Medical Group -73.93%-38.49%-20.09% Does the media refer more to BELL or CREO? In the previous week, Belluscura's average media sentiment score of 0.00 equaled Creo Medical Group'saverage media sentiment score. Company Overall Sentiment Belluscura Neutral Creo Medical Group Neutral Which has more risk and volatility, BELL or CREO? Belluscura has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500. Comparatively, Creo Medical Group has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Which has stronger valuation & earnings, BELL or CREO? Belluscura has higher earnings, but lower revenue than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than Belluscura, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBelluscura£1.80M9.40-£18.60M-£0.10-100.50Creo Medical Group£30.30M2.06-£22.40M-£0.06-287.50 Do institutionals & insiders have more ownership in BELL or CREO? 6.3% of Belluscura shares are held by institutional investors. Comparatively, 56.1% of Creo Medical Group shares are held by institutional investors. 56.3% of Belluscura shares are held by insiders. Comparatively, 22.4% of Creo Medical Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryBelluscura and Creo Medical Group tied by winning 6 of the 12 factors compared between the two stocks. Ad Behind the Markets📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Take these 4 steps to protect your retirement here >>> Get Belluscura News Delivered to You Automatically Sign up to receive the latest news and ratings for BELL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BELL vs. The Competition Export to ExcelMetricBelluscuraMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£16.93M£2.11B£5.18B£1.68BDividend YieldN/A2.32%5.18%6.84%P/E Ratio-100.50206.9667.001,794.23Price / Sales9.40204.751,269.05258,546.15Price / Cash8.0015.3839.9127.60Price / Book0.843.496.492.85Net Income-£18.60M£74.63M£120.13M£160.88M7 Day Performance-4.29%-0.39%-5.13%-0.64%1 Month Performance-8.64%4.71%-2.72%3.50%1 Year Performance-59.31%21.27%31.20%129.39% Belluscura Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BELLBelluscuraN/AGBX 10.05-2.0%N/A-61.3%£16.93M£1.80M-100.5024Gap DownCREOCreo Medical GroupN/AGBX 16.66-4.8%N/A-47.3%£60.25M£30.30M-277.58279Negative NewsGap UpHigh Trading VolumeIUGIntelligent Ultrasound GroupN/AGBX 11.65+1.3%N/A+21.1%£38.10M£9.88M-1,165.0065NCYTNovacytN/AGBX 49.230.0%N/A-4.6%£34.77M£18.56M-94.68120Gap DownPOLXPolarean ImagingN/AGBX 1.58+2.2%N/A-76.3%£19.17M£1.87M-79.2028Gap UpIHCInspiration Healthcare GroupN/AGBX 17+3.0%N/A-60.6%£15.24M£34.30M-121.43224News CoverageAVOAdvanced OncotherapyN/AGBX 1.75-9.1%N/A+0.0%£9.50MN/A-25.003,900Gap DownRUARUA Life SciencesN/AGBX 11.50+2.2%N/A-29.2%£7.14M£2.19M-287.4348MHCMyHealthCheckedN/AGBX 12-4.0%N/A+26.1%£6.24M£9.39M-600.0016Gap DownSUNSurgical Innovations GroupN/AGBX 0.55flatN/A-39.0%£5.13M£12.54M-21.1180Gap DownDEMGDeltex Medical GroupN/AGBX 0.09flatN/A-44.8%£1.62M£1.78M-5.7537Gap Down Related Companies and Tools Related Companies CREO Competitors IUG Competitors NCYT Competitors POLX Competitors IHC Competitors AVO Competitors RUA Competitors MHC Competitors SUN Competitors DEMG Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:BELL) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Belluscura plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Belluscura With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
